Ocugen Index Addition Highlights Rising Attention And Ongoing Gene Therapy Risks [Yahoo! Finance]
Ocugen, Inc. (OCGN)
Company Research
Source: Yahoo! Finance
Ocugen, Inc. (NasdaqCM:OCGN) has been added to the S&P Biotechnology Select Industry Index. This index inclusion marks a new milestone for the company within the biotechnology sector. Ocugen focuses on biotechnology, with programs that seek to address eye diseases and other medical needs. The S&P Biotechnology Select Industry Index tracks a group of biotech companies, and Ocugen's addition places it alongside a broader peer set that some investors and funds monitor closely. For readers, index inclusion can matter because certain institutional investors and index linked products may now consider or hold NasdaqCM:OCGN as part of their mandates. While this does not dictate how the share price will move, it creates a fresh reference point for how the market views the company's role in the biotech sector. Stay updated on the most important news stories for Ocugen by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on Ocug
Show less
Read more
Impact Snapshot
Event Time:
OCGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OCGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OCGN alerts
High impacting Ocugen, Inc. news events
Weekly update
A roundup of the hottest topics
OCGN
News
- Ocugen (OCGN) had its "buy" rating reaffirmed by Chardan Capital. They now have a $7.00 price target on the stock.MarketBeat
- Ocugen (OCGN) had its price target raised by HC Wainwright from $7.00 to $10.00. They now have a "buy" rating on the stock.MarketBeat
- Ocugen (OCGN) Has A Healthy Cash Position For 2026 [Yahoo! Finance]Yahoo! Finance
- Ocugen, Inc. (OCGN) Discusses Top Line Results From Phase II ArMaDa Trial of OCU410 in Geographic Atrophy Transcript [Seeking Alpha]Seeking Alpha
- Ocugen Shares Phase II OCU410 Data Showing 31% Slower GA Lesion Growth at 12 Months [Yahoo! Finance]Yahoo! Finance
OCGN
Earnings
- 3/4/26 - In-Line
OCGN
Sec Filings
- 3/24/26 - Form 8-K
- 3/20/26 - Form 8-K
- 3/5/26 - Form 3
- OCGN's page on the SEC website